The federal courts have pulled the plug on another prominent importer of Canadian prescription drugs, ruling that Canada Care Drugs Inc should be permanently enjoined from shipping pharmaceuticals to patients in the United States. The court's action was taken in the wake of an undercover investigation by FDA officials seeking to prevent cross-border sales of prescription medicines.

The kinds of products purchased undercover by the FDA from Canada Care "are often shipped with inadequate instructions for use or in inappropriate quantities that facilitate use of the product without the input of a physician that is needed to assure that the product is used in a manner to prevent serious, and even fatal, consequences," the agency official said.